Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia

Abstract

The invention relates to agents and preparations for the treatment or prevention of hyperglycemia, or for the stabilization of glycemia, based on the cell walls of yeast and preparation of a corresponding therapeutic composition.

1 . An agent for the treatment or prevention of hyperglycemia or for the stabilization of glycemia, said agent consisting of cell walls of yeast of the genus  Saccharomyces cerevisiae,  said yeast cell walls having:
 a total glucan and mannan content of 55% to 70% by mass on a dry matter basis, and   a glycogen content of less than 10.0% by mass on a dry matter basis.   
   
   
       2 . An agent according to  claim 1 , wherein the yeast cell walls have a total glucan and mannan content of less than or equal to 60% to 70% by mass on a dry matter basis. 
   
   
       3 . An agent according to  claim 2 , wherein the yeast cell walls have a total glucan and mannan content of 60% to 65% by mass on a dry matter basis. 
   
   
       4 . An agent according to  claim 1 , wherein the yeast cell walls have a glycogen content of less than 8.0% by mass on a dry matter basis. 
   
   
       5 . An agent according to  claim 4 , wherein the yeast cell walls have a glycogen content of less than 5.0% by mass on a dry matter basis. 
   
   
       6 . An agent according to  claim 5 , wherein the yeast cell walls have a glycogen content of less than 3.0% by mass on a dry matter basis. 
   
   
       7 . An agent according to  claim 6 , wherein the yeast cell walls have a glycogen content of less than 1.0% by mass on a dry matter basis. 
   
   
       8 . An agent according to  claim 7 , wherein the yeast cell walls have a glycogen content of less than 0.1% by mass on a dry matter basis. 
   
   
       9 . An agent according to  claim 1 , wherein the yeast cell walls have a dry matter content greater than or equal to 90% by mass. 
   
   
       10 . An agent according to  claim 9 , wherein the yeast cell walls have a dry matter content greater than or equal to 94% by mass. 
   
   
       11 . An agent according to  claim 10 , wherein the yeast cell walls have a dry matter content greater than or equal to 96% by mass. 
   
   
       12 . An agent according to  claim 1 , wherein hyperglycemia is a hyperglycemia in the case of type 2 diabetes. 
   
   
       13 . An agent according to  claim 1 , for the stabilization of glycemia in the case of type 2 diabetes. 
   
   
       14 . A preparation for the treatment or prevention of hyperglycemia or for the stabilization of glycemia, comprising the agent according to  claim 1 . 
   
   
       15 . A preparation according to  claim 14 , wherein hyperglycemia is a hyperglycemia in the case of type 2 diabetes. 
   
   
       16 . A preparation according to  claim 14 , for the stabilization of glycemia in the case of type 2 diabetes.